Second Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements
Launched by TOPCON MEDICAL SYSTEMS, INC. · Apr 22, 2015
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria - Non-Pathologic Young Adults (18-28 years old) and Non-Pathologic Adults (29-80 years old):
- • Male or female subjects from 18 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed;
- • Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date;
- • Subjects who agree to participate in the study.
- • Inclusion Criteria - Pathologic Adults (29-80 years old)
- • Male and female subjects from 29 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed;
- • Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date;
- • Subjects who agree to participate in the study;
- * At least one eye with any of the following conditions:
- • History of post-op surgical trauma including Pseudophakic or Aphakic bullous keratopathy;
- • History of corneal transplant;
- • Physical injury or trauma to the cornea;
- • Long term Fuch's dystrophy, Guttata, or other corneal endothelial dystrophies
- • Keratoconus;
- • Long term polymethyl methacrylate PMMA contact lens use (greater than 3 years).
- • Exclusion Criteria - Non-Pathologic Young Adults (18-28 years old) and Non Pathologic Adults (29-80 years old)
- • History of post-op surgical trauma including bullous keratopathy;
- • History of corneal transplant;
- • Evidence of physical injury or trauma to the cornea;
- • Long term Fuch's dystrophy, Guttata or other corneal endothelial dystrophies;
- • Keratoconus;
- • Long term PMMA contact lens use (greater than 3 years);
- • History of cataract, refractive or ocular surgical procedures that render the cornea opaque or otherwise impact its ability to be imaged using the investigational device;
- • Fixation problems which may prevent obtaining good quality SP-1P and CELLCHEK PLUS in either eye.
- Exclusion Criteria - Pathologic Adults (29-80 years old):
- • History of cataract, refractive or ocular surgical procedures that render the cornea opaque or otherwise impact its ability to be imaged using the investigational device;
- • Fixation problems which may prevent obtaining good quality SP-1P and CELLCHEK PLUS in either eye.
About Topcon Medical Systems, Inc.
Topcon Medical Systems, Inc. is a leading provider of advanced ophthalmic equipment and technology, dedicated to enhancing the diagnosis and treatment of eye care conditions. With a commitment to innovation and quality, Topcon develops a comprehensive range of diagnostic instruments and software solutions that empower eye care professionals to deliver superior patient care. The company actively engages in clinical trials to advance the field of ophthalmology, ensuring that their products meet the highest standards of efficacy and safety. Through collaboration with healthcare providers and researchers, Topcon aims to improve patient outcomes and drive advancements in vision science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Andover, Massachusetts, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials